Primary tabs

A Randomized Double-Blind Active- and Placebo-Controlled Parallel-Group Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release Paliperidone Compared with Flexibly-Dosed Quetiapine and Placebo in the Treatment of...

The primary objectives of the study are to demonstrate the antimanic efficacy and to assess the safety of flexibly dosed paliperidone extended release ER compared with placebo during 3 weeks of treatment in subjects with Bipolar I Disorder who are experiencing an acute manic or mixed episode